Vyome Therapeutics News and Activities

Vyome Therapeutics is a company listed under the stock ticker HIND (IN).

Acquisition, funding and merger involving Vyome Therapeutics.

• Vyome Therapeutics is now listed under ticker HIND. (posted on August 15 2025).
• Vyome Therapeutics and ReShape Lifesciences have announced they will merge  (posted on January 14 2025)..

View the org chart displaying its 8 main executives

Most searched biographies at Vyome Therapeutics

• Venkat Nelabhotla, Chief Executive Officer and Director
• S Sengupta, Board Member
• John Tincoff, Director

Create your alert
to follow the executive moves at Vyome Therapeutics.

Vyome Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Vyome Therapeutics

Social media about Vyome Therapeutics

• Vyome Therapeutics on Wikipedia, Google News & Yahoo Finance
• Vyome Therapeutics on LinkedIn, X (Twitter) & YouTube